Skip to main content
. 2020 Jan 23;10:7. doi: 10.3389/fonc.2020.00007

Table 3.

Proportion of patients not receiving concomitant treatment after induction TPF.

PARADIGM DeCIDE TTCC trial TPF arm GSTTC
trial
GORTEC 2007.02
Never started RT:  - PD  -Early deaths  -Toxicity  -Others 10%
nr
1.4§
nr
nr
8.8%
nr
2.9%
nr
nr
30.7%
2.6%
5.2%
11.7%
11.1%
10%
4%
1%
2.4%
2.6%
16.5%
5.5%
6.6%
nr
4.4%

PD, progressive disease.

§

total early deaths for IC + concomitant.